N

Nissan Medical Industries Ltd
TASE:NISA

Watchlist Manager
Nissan Medical Industries Ltd
TASE:NISA
Watchlist
Price: 1 606 ILS -0.43% Market Closed
Market Cap: 150.9m ILS
Have any thoughts about
Nissan Medical Industries Ltd?
Write Note

Nissan Medical Industries Ltd
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nissan Medical Industries Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
N
Nissan Medical Industries Ltd
TASE:NISA
Cash & Cash Equivalents
â‚Ş11.4m
CAGR 3-Years
-42%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
InspireMD Inc
NASDAQ:NSPR
Cash & Cash Equivalents
$15.8m
CAGR 3-Years
7%
CAGR 5-Years
17%
CAGR 10-Years
12%
A
Allmed Solutions Ltd
TASE:ALMD
Cash & Cash Equivalents
â‚Ş6.7m
CAGR 3-Years
-12%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
No Stocks Found

Nissan Medical Industries Ltd
Glance View

Market Cap
150.9m ILS
Industry
Health Care

Nissan Medical Industries Ltd. engages in production and marketing of non-woven fabrics. The firm supplies its products to medical centers and pharmacies, as well as defense forces and private hospitals in Israel and abroad. The firm offers a range of products, including gauze and non-woven swabs, absorbent pads, absorbent balls, laparotomy sponges, bandages, kits, double peel-packs, and orthopedic padding, among others.

NISA Intrinsic Value
5 362.24 ILS
Undervaluation 70%
Intrinsic Value
Price
N

See Also

What is Nissan Medical Industries Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
11.4m ILS

Based on the financial report for Jun 30, 2024, Nissan Medical Industries Ltd's Cash & Cash Equivalents amounts to 11.4m ILS.

What is Nissan Medical Industries Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-3%

Over the last year, the Cash & Cash Equivalents growth was -60%. The average annual Cash & Cash Equivalents growth rates for Nissan Medical Industries Ltd have been -42% over the past three years , -3% over the past five years .

Back to Top